发明名称 |
EARLY DETECTION OF PREECLAMPSIA |
摘要 |
The invention provides non-invasive assays to reliably identify women who have or are predisposed to developing preeclampsia (PE). The method comprises measuring a level of annexin A2 (ANXA2) in a test sample obtained of a subject; and identifying the subject as having preeclampsia or at an increased risk of developing preeclampsia when the level of ANXA2 in the test sample is decreased in relation to a control sample. Methods to treat subject identified as having PE or at an increased risk of developing preeclampsia are also provided. |
申请公布号 |
US2017097358(A1) |
申请公布日期 |
2017.04.06 |
申请号 |
US201515127901 |
申请日期 |
2015.03.19 |
申请人 |
Igenomix S.L. |
发明人 |
Simón Carlos;Garrido Tamara;Pellicer Antonio |
分类号 |
G01N33/68;A61K31/727 |
主分类号 |
G01N33/68 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for treating preeclampsia, the method comprising:
determining whether a subject is at an increased risk of developing preeclampsia by measuring a level of annexin A2 (ANXA2) in a test sample obtained of the subject, comparing the level of ANXA2 in the test sample to a control level of ANXA2 to determine if the subject is at an increased risk of developing preeclampsia; and administering to the subject determined to be at an increased risk of developing preeclampsia an effective amount of a glycosaminoglycan. |
地址 |
Valencia ES |